Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses. [electronic resource]
Producer: 20190919Description: 57-67 p. digitalISSN:- 1872-9096
- Alphavirus -- drug effects
- Animals
- Antineoplastic Agents -- pharmacology
- Antiviral Agents -- pharmacology
- Cell Line
- Drug Evaluation, Preclinical -- methods
- Drug Repositioning
- Genes, Reporter
- High-Throughput Screening Assays
- Luciferases -- analysis
- Luminescent Measurements
- Reverse Genetics
- Sorafenib -- pharmacology
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.